Restricted accessResearch articleFirst published online 2019-3
Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques
Depletion of gut T helper 17 (Th17) cells during HIV infection leads to decreased mucosal integrity and increased disease progression. Conversely, T regulatory (Treg) cells may inhibit antiviral responses or immune activation. In HIV elite controllers, a balanced Th17/Treg ratio is maintained in the blood, suggesting a role for these responses in controlling inflammation and viral replication. HIV-infected individuals exhibit a range in responsiveness to combination antiretroviral therapy (cART). Given the link between the Th17/Treg ratio and HIV disease, we reasoned these responses may play a role in cART responsiveness. In this study, we investigated the relationship between the mucosal Th17/Treg ratio to acute simian immunodeficiency virus (SIV) viremia and the response to cART. Nineteen rhesus macaques were infected with highly pathogenic SIVΔB670 virus and cART was initiated 6 weeks postinfection. Mucosal CD4 T cell subsets were assessed by intracellular cytokine staining in the colon and mesenteric lymph nodes. Higher baseline Th17/Treg ratios corresponded with increased acute SIV viremia. Th17/Treg ratios decreased during acute SIV infection and were not restored during cART, and this corresponded to increased gut immune activation (Ki67+), markers of microbial translocation (sCD14), and T cell exhaustion (TIGIT+). Animals that maintained a more balanced mucosal Th17/Treg ratio at the time of cART initiation exhibited a better virological response to cART and maintained higher peripheral CD4 counts. These results suggest mucosal Th17 and Treg homeostasis influences acute viremia and the response to cART, a result that suggests therapeutic interventions that improve the Th17/Treg ratio before or during cART may improve treatment of HIV.
Get full access to this article
View all access options for this article.
References
1.
HongFF, MellorsJW: Changes in HIV reservoirs during long-term antiretroviral therapy. Curr Opin HIV AIDS, 2015; 10:43–48.
2.
BettelliE, CarrierY, GaoW, et al.: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 2006; 441:235–238.
3.
CecchinatoV, TrindadeCJ, LaurenceA, et al.: Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol, 2008; 1:279–288.
4.
PallikkuthS, MicciL, EndeZS, et al.: Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21. PLoS Pathog, 2013; 9:e1003471.
5.
MaddurMS, MiossecP, KaveriSV, BayryJ: Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol, 2012; 181:8–18.
6.
KanwarB, FavreD, McCuneJM: Th17 and regulatory T cells: Implications for AIDS pathogenesis. Curr Opin HIV AIDS, 2010; 5:151–157.
7.
MacatangayBJ, RinaldoCR: Regulatory T cells in HIV immunotherapy. HIV Ther, 2010; 4:639–647.
8.
ChevalierMF, WeissL: The split personality of regulatory T cells in HIV infection. Blood, 2013; 121:29–37.
9.
FaliveneJ, GhiglioneY, LauferN, et al.: Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression. Sci Rep, 2015; 5:11511.
10.
FavreD, LedererS, KanwarB, et al.: Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog, 2009; 5:e1000295.
11.
FullerDH, RajakumarP, CheJW, et al.: Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques. PLoS One, 2012; 7:e33715.
12.
SmedleyJ, MacalisterR, WangariS, et al.: Laparoscopic technique for serial collection of para-colonic, left colic, and inferior mesenteric lymph nodes in macaques. PLoS One, 2016; 11:e0157535.
13.
MunsonP, LiuY, BrattD, et al.: Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection. Hum Vaccines Immunother, 2018; 14:1820–1831.
14.
DembergT, FloreseRH, HeathMJ, et al.: A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol, 2007; 81:3414–3427.
15.
SPICE: Exploration and analysis of post-cytometric complex multivariate datasets—Roederer—Cytometry Part A—Wiley Online Library [Internet]. Available at https://onlinelibrary.wiley.com/doi/abs/10.1002/cyto.a.21015 (2011), accessed September17, 2018.
16.
Murphey-CorbM, WilsonLA, TrichelAM, et al.: Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J Immunol, 1999; 162:540–549.
17.
PotterSJ, LacabaratzC, LambotteO, et al.: Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: An ANRS EP36 study. J Virol, 2007; 81:13904–13915.
18.
Muñoz-CallejaC, CostantiniA, SilvestriG, et al.: Highly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations. AIDS, 2001; 15:1887–1890.
19.
Serrano-VillarS, SainzT, LeeSA, et al.: HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog, 2014; 10:e1004078.
20.
BuggertM, FrederiksenJ, NoyanK, et al.: Multiparametric bioinformatics distinguish the CD4/CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection. J Immunol, 2014; 192:2099–2108.
21.
ChevalierMF, DidierC, PetitjeanG, et al.: Phenotype alterations in regulatory T-cell subsets in primary HIV infection and odentification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells. J Infect Dis, 2015; 211:769–779.
22.
PrendergastA, PradoJG, KangYH, et al.: HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS, 2010; 24:491–502.
23.
RyanES, MicciL, FromentinR, et al.: Loss of function of intestinal IL-17 and IL-22 producing cells contributes to inflammation and viral persistence in SIV-infected rhesus macaques. PLoS Pathog, 2016; 12:e1005412.
24.
SchuetzA, DeleageC, SeretiI, et al.: Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog, 2014; 10:e1004543.
25.
KimCJ, RousseauR, HuibnerS, et al.: Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers. AIDS, 2017; 31:1529–1534.
26.
LiD, ChenJ, JiaM, et al.: Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection. Clin Exp Immunol, 2011; 165:363–371.
27.
ChegeD, ShethPM, KainT, et al.: Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy. AIDS, 2011; 25:741–749.
28.
FrenchMA, KingMS, TschampaJM, da SilvaBA, LandayAL: Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. J Infect Dis, 2009; 200:1212–1215.
29.
PiconiS, TrabattoniD, GoriA, et al.: Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy. AIDS, 2010; 24:1991–2000.
30.
HuntPW, CaoHL, MuzooraC, et al.: Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS, 2011; 25:2123–2131.
31.
SandlerNG, WandH, RoqueA, et al.: Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis, 2011; 203:780–790.
32.
BrenchleyJM, PriceDA, SchackerTW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med, 2006; 12:1365–1371.
33.
HandleySA, DesaiC, ZhaoG, et al.: SIV infection-mediated changes in gastrointestinal bacterial microbiome and virome are associated with immunodeficiency and prevented by vaccination. Cell Host Microbe, 2016; 19:323–335.
34.
ChewGM, FujitaT, WebbGM, et al.: TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection. PLoS Pathog, 2016; 12:e1005349.
35.
TauriainenJ, ScharfL, FrederiksenJ, et al.: Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep, 2017; 7:40354.
36.
StiehDJ, MatiasE, XuH, et al.: Th17 cells are preferentially infected very early after vaginal transmission of SIV in macaques. Cell Host Microbe, 2016; 19:529–540.
37.
GordonSN, CervasiB, OdorizziP, et al.: Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. J Immunol, 2010; 185: 5169–5179.
38.
KlattNR, HarrisLD, VintonCL, et al.: Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol, 2010; 3:387–398.
39.
JenabianMA, PatelM, KemaI, et al.: Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers. PLoS One, 2013; 8:e78146.
40.
ChaseAJ, SedaghatAR, GermanJR, et al.: Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection. J Virol, 2007; 81:12748–12757.
41.
GeorgeJ, CofanoEB, LybargerE, et al.: Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques. AIDS Res Hum Retroviruses, 2011; 27:763–775.
42.
KhowawisetsutL, PattanapanyasatK, OnlamoonN, et al.: Relationships between IL-17(+) subsets, Tregs and pDCs that distinguish among SIV infected elite controllers, low, medium and high viral load rhesus macaques. PLoS One, 2013; 8:e61264.
43.
ShawJM, HuntPW, CritchfieldJW, et al.: Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses, 2013; 29:172–177.
44.
HuntPW, MartinJN, SinclairE, et al.: T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis, 2003; 187:1534–1543.
45.
LingB, MohanM, LacknerAA, et al.: The large intestine as a major reservoir for simian immunodeficiency virus in macaques with long-term, nonprogressing infection. J Infect Dis, 2010; 202:1846–1854.
46.
VeazeyRS, DeMariaM, ChalifouxLV, et al.: Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science, 1998; 280:427–431.
47.
CassolE, MalfeldS, MahashaP, et al.: Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy. J Infect Dis, 2013; 208:1113–1122.
48.
XuH, WangX, VeazeyRS: Th17 cells coordinate with Th22 cells in maintaining homeostasis of intestinal tissues and both are depleted in SIV-infected macaques. J AIDS Clin Res, 2014; 5:302.
49.
NigamP, KwaS, VeluV, AmaraRR: Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J Immunol, 2011; 186:745–753.
50.
TrichelAM, RajakumarPA, Murphey-CorbM: Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol, 2002; 31:171–178.
51.
LingB, VeazeyRS, LuckayA, et al.: SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS, 2002; 16:1489–1496.
52.
KlattNR, CanaryLA, VanderfordTH, et al.: Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques. J Virol, 2012; 86:1203–1213.
53.
SinghA, VajpayeeM, AliSA, MojumdarK, ChauhanNK, SinghR: HIV-1 diseases progression associated with loss of Th17 cells in subtype “C” infection. Cytokine, 2012; 60:55–63.
54.
SaxenaV, PatilA, TaydeR, et al.: HIV-specific CD4+Th17 cells from HIV infected long-term non-progressors exhibit lower CTLA-4 expression and reduced apoptosis. Immunobiology, 2018; 223:658–662.
55.
JollerN, LozanoE, BurkettPR, et al.: Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity, 2014; 40:569–581.
56.
AddoMM, AltfeldM: Sex-based differences in HIV type 1 pathogenesis. J Infect Dis, 2014; 209(Suppl 3):S86–S92.
57.
RenW, MaY, YangL, et al.: Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial response. AIDS, 2015; 29:F1–F8.
58.
MacalM, SankaranS, ChunTW, et al.: Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol, 2008; 1:475–488.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
